CAI — Caris Life Sciences, Inc. stock price, charts and financials

QT27Caris Life Sciences, Inc.

Caris Life Sciences, Inc. (NASDAQ: CAI) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
16.10
-0.22-1.35%
OverviewShort InterestFilings
CAIQT27Caris Life Sciences, Inc.·NASDAQ
16.10-1.35%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Jul 13, 20264Statement of changes in beneficial ownership
Jun 25, 2026ABS-15GABS-15G
Jun 16, 2026CERTCERT
Jun 16, 20268-A12B8-A12B
Jun 05, 20268-KCurrent report
Jun 02, 20264Statement of changes in beneficial ownership
Jun 02, 20264Statement of changes in beneficial ownership
May 18, 20264Statement of changes in beneficial ownership
May 18, 20264Statement of changes in beneficial ownership
May 18, 20264Statement of changes in beneficial ownership
May 18, 20264Statement of changes in beneficial ownership
May 18, 20264Statement of changes in beneficial ownership
May 12, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 12, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 12, 20264Statement of changes in beneficial ownership
May 08, 202610-QQuarterly report
May 07, 20268-KCurrent report
Apr 23, 2026DEFA14AAdditional proxy soliciting materials
Apr 23, 2026ARSAnnual report to shareholders
Apr 23, 2026DEF 14ADefinitive proxy statement
Apr 07, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Apr 02, 20268-KCurrent report
Mar 10, 20264Statement of changes in beneficial ownership
Mar 10, 20264Statement of changes in beneficial ownership
Mar 10, 20264Statement of changes in beneficial ownership
#1 / 25 of 107
Page
▼
/ 5